Skip to main content Accessibility help
×
Home

Ten years' experience with clozapine in treatment-resistant schizophrenic patients: Factors indicating the therapeutic response

  • E Alvarez (a1), F Barón (a1), J Perez-Blanco (a1), D Puigdemont José Soriano (a1), C Masip (a1) and V Perez-Solá (a1)...

Summary

A prospective study in treatment-resistant schizophrenic patients was performed over 10 years to evaluate the therapeutic response to clozapine and the variables related to this treatment. Eighty schizophrenic and schizoaffective patients (according to Diagnostic and Statistical Manual [DSM]-IIIR criteria), considered as refractory (previously resistant to at least two different typical neuroleptics), were studied. The average dose of clozapine was 267 mg/d. The clinical variables considered were: Brief Psychiatric Rating Scale (BPRS), number of admissions before and after clozapine treatment and the Strauss-Carpenter scale as measures of efficacy; Premorbid Adjustment Scale (PAS), to assess personal and social adjustment before illness; Karolinska Personality Scale (KPS) to assess stable traits of personality; and the Simpson-Angus scale as a measure of extrapyramidal symptoms. Sixty percent of patients showed a significant improvement after clozapine treatment. Side-effects were mild and well tolerated, with no cases of haematological disturbance and only five withdrawals because of adverse events. The severity of the episode, according to BPRS score and anxiety as a personal trait, are related to good prognosis. Other relationships between improvement and clinical and demographic variables are discussed.

Copyright

References

Hide All
Alvarez, EGarcia, CTorrens, MUdina, CGuillamat, RCasas, M. Premorbid adjustment scale as a prognostic predictor for schizophrenia (Letter). Br J Psychiatry 1987; 150: 411
Cannon-Spoor, HEPotkin, SGWyatt, RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982; 8: 470484
Faraone, SVBrown, WALaughren, TP. Serum neuroleptic levels, prolactin levels and relapse: a two year study of schizophrenic patients. J Clin Psychiatry 1987; 48: 151154
Garcia Ribera, CTorrens, MGuillamat, RRuiz, IUdina, CCasas, MAlvarez, E. La escala de ajuste premórbido y el pronóstico de la esquizofrenia. Sant Pau 1986; 7: 95
Garcia Ribera, CTorrens, MGuillamat, RRuiz, IUdina, CCasas, MAlvarez, E. La escala de ajuste premórbido y el pronóstico de la esquizofrenia. Sant Pau 1986; 7: 103
Kane, JMHonigfeld, GSinger, JMeltzer, HThe Clozaril Collaborative Study Group. Clozapine for the treatment resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45 1988 789796
Kay, SRSingh, MM. The positive-negative distinction in drug-free schizophrenic patients. Arch Gen Psychiatry 1989; 46: 711718
Klinteberg, BSchalling, DMagnusson, DIndividual development and adjustment. Self-report assessment of personality traits. Geneva: University of Stockholm, Department of Psychology, 1986
Meltzer, HYClozapine. Pattern of efficacy in treatment-resistant schizophreniaMeltzer, HYNovel antipsychotic drugs Stockholm: Raven Press, 1992; 3346
Ministerio de Sanidad y Consumo. Centro Nacional de Farmacobiologia, Area de Farmacologia. Programa de Seguimiento de Clozapina. Boletin Informativo no 2 1996
Nasrallah, HARelationship of structural brain changes to antipsychotic drug response in schizophreniaShiriqui, CLNasrallah, HAContemporary issues in the treatment of schizophrenia New York: American Psychiatry Press, 1995; 209223
Ortet-Fabregat, GTorrubia, R. Spanish language version of the Karolinska Scales of Personality (KPS): first data. 6th European Association for Personality Psychology ConferenceGroningen, The Netherlands1994
Overall, JEGorham, DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799812
Pickar, DOwen, RRLitman, RE. Clinical and biologic response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiatry 1992; 49: 345353
Simpson, GMAngus, JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 46: 1119
Strauss, JSCarpenter, WT. The prediction of outcome in schizophrenia. I. Characteristics of outcome. Arch Gen Psychiatry 1972; 27: 739746

Keywords

Ten years' experience with clozapine in treatment-resistant schizophrenic patients: Factors indicating the therapeutic response

  • E Alvarez (a1), F Barón (a1), J Perez-Blanco (a1), D Puigdemont José Soriano (a1), C Masip (a1) and V Perez-Solá (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Ten years' experience with clozapine in treatment-resistant schizophrenic patients: Factors indicating the therapeutic response

  • E Alvarez (a1), F Barón (a1), J Perez-Blanco (a1), D Puigdemont José Soriano (a1), C Masip (a1) and V Perez-Solá (a1)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *